Study: AstraZeneca vaccine effective against Brazil variant | The Daily Star
12:00 AM, March 06, 2021 / LAST MODIFIED: 02:12 AM, March 06, 2021

Study: AstraZeneca vaccine effective against Brazil variant

Preliminary data from a study conducted at the University of Oxford indicates that the Covid-19 vaccine developed by AstraZeneca PLC is effective against the P1, or Brazilian, variant, a source with knowledge of the study told Reuters yesterday. The data indicates that the vaccine will not need to be modified in order to protect against the variant, which is believed to have originated in the Amazonian city of Manaus, said the source. The source did not provide the exact efficacy of the vaccine against the variant. They said the full results of the study should be released soon, possibly in March. Early results indicated the AstraZeneca vaccine was less effective against the South African variant, which is similar to P1. South Africa subsequently paused the use of the vaccine in the country.

 

For all latest news, follow The Daily Star's Google News channel.

Stay updated on the go with The Daily Star Android & iOS News App. Click here to download it for your device.

Grameenphone:
Type START <space> BR and send SMS it to 22222

Robi:
Type START <space> BR and send SMS it to 2222


Banglalink:
Type START <space> BR and send SMS it to 2225

Leave your comments

Top News

Top News

Top